ESAs have also been shown to be effective in improving Hb levels and quality of life in several chronic conditions (dialysis [35], chronic heart failure [36], cancer [41], rheumatoid arthritis [42]), although an increased risk for thromboembolism and mortality was found in some studies [43]. Here, GSTM1 is linked to congestive heart failure.